General Information of the Disease (ID: DIS00025)
Name
Oesophageal cancer
ICD
ICD-11: 2B70
Full List of Target(s) of This Ferroptosis-centered Disease
Phospholipid hydroperoxide glutathione peroxidase (GPX4)
In total 12 item(s) under this target
Experiment 1 Reporting the Ferroptosis-centered Disease Response by This Target [1]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal cancer [ICD-11: 2B70]
Responsed Drug Oridonin Investigative
Responsed Regulator Glutathione hydrolase 1 proenzyme (GGT1) Suppressor
Pathway Response Glutathione metabolism hsa00480
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
Response regulation The levels of intracellular iron, malondialdehyde, and reactive oxygen species after oridonin (Ori) treatment, while interfering with the effects of Ori with ferroptosis inhibitor, demonstrating that Ori's inhibition of TE1( esophageal cancer cell) cell proliferation is associated with ferroptosis. Ori can inhibit the gamma-glutamyl cycle by inhibiting the activity of GGT1 and binding to cysteine, thereby inducing ferroptosis to exert anti-cancer activity. Eventually, the value of intracellular GSH/GSSG was reduced, and the enzymatic activity of the glutathione peroxidase 4 (GPX4) was significantly decreased.
Experiment 2 Reporting the Ferroptosis-centered Disease Response by This Target [1]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal cancer [ICD-11: 2B70]
Responsed Drug Oridonin Investigative
Responsed Regulator Glutathione hydrolase 1 proenzyme (GGT1) Suppressor
Pathway Response Glutathione metabolism hsa00480
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
Response regulation The levels of intracellular iron, malondialdehyde, and reactive oxygen species after oridonin (Ori) treatment, while interfering with the effects of Ori with ferroptosis inhibitor, demonstrating that Ori's inhibition of TE1(esophageal cancer cell) cell proliferation is associated with ferroptosis. Ori can inhibit the gamma-glutamyl cycle by inhibiting the activity of GGT1 and binding to cysteine, thereby inducing ferroptosis to exert anti-cancer activity. Eventually, the value of intracellular GSH/GSSG was reduced, and the enzymatic activity of the glutathione peroxidase 4 (GPX4) was significantly decreased.
Experiment 3 Reporting the Ferroptosis-centered Disease Response by This Target [4]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Drug 5-aminolevulinic acid Approved
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model KYSE30 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1351
KYSE-510 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1354
MKN45 cells Gastric adenocarcinoma Homo sapiens CVCL_0434
In Vivo Model
KYSE30 cells were subcutaneously inoculated with 5 x 106 cells per site into both flanks on day 0. At 1 week after transplantation, tumor-bearing mice were randomly assigned to one of the following three groups: (1) saline as a control, (2) 10 mg/kg/day of 5-ALA, or (3) 30 mg/kg/day of 5-ALA. The treatment groups were orally administered 5-ALA once daily for 4 weeks, and the control group was orally administered saline during the same period.

    Click to Show/Hide
Response regulation Modulation of GPX4 and HMOX1 by 5-aminolevulinic acid (5-ALA) induced ferroptosis in esophageal squamous cell carcinoma (ESCC). Furthermore, 5-ALA led to an increase in lipid peroxidation and exerted an antitumor effect in various cancer cell lines, which was inhibited by ferrostatin-1. Thus, 5-ALA could be a promising new therapeutic agent for ESCC.
Experiment 4 Reporting the Ferroptosis-centered Disease Response by This Target [5]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator DnaJ homolog subfamily B member 6 (DNAJB6) Driver
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
KYSE150 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1348
KYSE-450 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1353
In Vivo Model
Female BALB/c athymic nude mice (4 weeks of age) were obtained from the HFK Bioscience Co, Beijing. To generate murine subcutaneous tumors, 2 x 106 Eca109 cells and KYSE 150 cells in 100 ul PBS were injected subcutaneously on the left of the nude mices dorsal midline. The xenografts were measured every 4 days.

    Click to Show/Hide
Response regulation The correlation between DNAJB6 level and lymph node metastasis in esophageal squamous cell carcinoma (ESCC) patient was negative. Overexpressing DNAJB6a shows tumor-suppressive effects in vitro and in vivo. In addition, DNAJB6a overexpression was accompanied together with a remarkable reduction in the protein levels of GPX4 and phosphorylated AKT (p-AKT).
Experiment 5 Reporting the Ferroptosis-centered Disease Response by This Target [6]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator Frizzled-3 (FZD3) Suppressor
Pathway Response Wnt signaling pathway hsa04310
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell invasion
In Vitro Model EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
KYSE-70 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1356
hEECs (Human esophageal epithelial cells)
In Vivo Model
BALB/c nude male mice of 4 weeks old were purchased from the Model Animal Research Center of Nanjing University (Nanjing, China). After one week of adaptive feeding, EC9706 cells (3 x 106) stably expressing sh-NC and sh-circPVT1, sh-NC + 5-FU and sh-circPVT1 + 5-FU were subcutaneously were injected into the right flank of the nude mice in a serum-free DMEM medium.

    Click to Show/Hide
Response regulation CircPVT1 regulated the chemosensitivity of esophageal squamous cell carcinoma cells through ROS and Wnt/-catenin pathwaysviamiR-30a-5p/FZD3. Knockdown of circPVT1 promoted chemosensitivity in ESCC by increasing ferroptosis via downregulating GPX4 and SLC7A11.
Experiment 6 Reporting the Ferroptosis-centered Disease Response by This Target [7]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal cancer [ICD-11: 2B70]
Responsed Regulator Transportin-1 (TNPO1) Driver
Pathway Response Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
Cell invasion
In Vitro Model Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
In Vivo Model
Nude mice of both sexes (age: 6-8 weeks, weight: 22-25 g) were purchased from HUNAN SJA LABRATORY ANIMAL CO., LTD (Hunan, China). The EC109 cells stably expressing sh-circBCAR3 or sh-nc were established by infection with corresponding lentivirus vectors. 1 x 106 mL-1 (100 uL) cells were subcutaneously inoculated into the nude mice. The tumor volumes had been measured from day 5 to day 25. On day 25, the xenograft tumors were removed surgically, and the tumor weight was detected.

    Click to Show/Hide
Response regulation CircBCAR3 binds with miR-27a-3p to promote TNPO1 expression. GPX4 protein levels were increased by silencing of circBCAR3. And circBCAR3 promoted the proliferation, migration, invasion, and ferroptosis of esophageal cancer cells by miR-27a-3p.
Experiment 7 Reporting the Ferroptosis-centered Disease Response by This Target [8]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator Cysteine--tRNA ligase, cytoplasmic (CARS1) Driver
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
Cell invasion
In Vitro Model KYSE30 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1351
KYSE-410 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1352
Response regulation CARS1 significantly inhibited cell proliferation, and the ability of migration and invasion promoted the relative level of MDA and ROS and decreased GPX4 expression level in two esophageal squamous cell carcinoma(ESCC) cell lines.
Experiment 8 Reporting the Ferroptosis-centered Disease Response by This Target [7]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal cancer [ICD-11: 2B70]
Responsed Regulator hsa-miR-27a-3p (miRNA) Suppressor
Pathway Response Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
Cell invasion
In Vitro Model Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
In Vivo Model
Nude mice of both sexes (age: 6-8 weeks, weight: 22-25 g) were purchased from HUNAN SJA LABRATORY ANIMAL CO., LTD (Hunan, China). The EC109 cells stably expressing sh-circBCAR3 or sh-nc were established by infection with corresponding lentivirus vectors. 1 x 106 mL-1 (100 uL) cells were subcutaneously inoculated into the nude mice. The tumor volumes had been measured from day 5 to day 25. On day 25, the xenograft tumors were removed surgically, and the tumor weight was detected.

    Click to Show/Hide
Response regulation CircBCAR3 binds with miR-27a-3p to promote TNPO1 expression. GPX4 protein levels were increased by silencing of circBCAR3. And circBCAR3 promoted the proliferation, migration, invasion, and ferroptosis of esophageal cancer cells by miR-27a-3p.
Experiment 9 Reporting the Ferroptosis-centered Disease Response by This Target [6]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator hsa-miR-30a-5p (miRNA) Driver
Pathway Response Wnt signaling pathway hsa04310
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell invasion
In Vitro Model EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
KYSE-70 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1356
hEECs (Human esophageal epithelial cells)
In Vivo Model
BALB/c nude male mice of 4 weeks old were purchased from the Model Animal Research Center of Nanjing University (Nanjing, China). After one week of adaptive feeding, EC9706 cells (3 x 106) stably expressing sh-NC and sh-circPVT1, sh-NC + 5-FU and sh-circPVT1 + 5-FU were subcutaneously were injected into the right flank of the nude mice in a serum-free DMEM medium.

    Click to Show/Hide
Response regulation CircPVT1 regulated the chemosensitivity of esophageal squamous cell carcinoma cells through ROS and Wnt/-catenin pathwaysvia miR-30a-5p/FZD3. Knockdown of circPVT1 promoted chemosensitivity in ESCC by increasing ferroptosis via downregulating GPX4 and SLC7A11.
Experiment 10 Reporting the Ferroptosis-centered Disease Response by This Target [9]
Target for Ferroptosis Suppressor
Responsed Disease Oesophageal carcinoma [ICD-11: 2B70]
Responsed Regulator OIP5-AS1 (IncRNA) Suppressor
Pathway Response Ferroptosis hsa04216
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
TE-13 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_4463
TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
T.Tn cells Esophageal squamous cell carcinoma Homo sapiens CVCL_3175
hOECs (Normal oesophageal epithelial cells)
Response regulation OIP5-AS1 inhibition significantly inhibited Oesophageal cancer (EC) cell viability and proliferation, induced ferroptosis, and downregulated GPX4 levels, while GPX4 reversed these effects.
Experiment 11 Reporting the Ferroptosis-centered Disease Response by This Target [6]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator CircPVT1 (circRNA) Suppressor
Pathway Response Wnt signaling pathway hsa04310
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell invasion
In Vitro Model EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
KYSE-70 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1356
hEECs (Human esophageal epithelial cells)
In Vivo Model
BALB/c nude male mice of 4 weeks old were purchased from the Model Animal Research Center of Nanjing University (Nanjing, China). After one week of adaptive feeding, EC9706 cells (3 x 106) stably expressing sh-NC and sh-circPVT1, sh-NC + 5-FU and sh-circPVT1 + 5-FU were subcutaneously were injected into the right flank of the nude mice in a serum-free DMEM medium.

    Click to Show/Hide
Response regulation CircPVT1 regulated the chemosensitivity of esophageal squamous cell carcinoma cells through ROS and Wnt/-catenin pathwaysviamiR-30a-5p/FZD3. Knockdown of circPVT1 promoted chemosensitivity in ESCC by increasing ferroptosis via downregulating GPX4 and SLC7A11.
Experiment 12 Reporting the Ferroptosis-centered Disease Response by This Target [7]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal cancer [ICD-11: 2B70]
Responsed Regulator CircBCAR3 (circRNA) Driver
Pathway Response Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
Cell invasion
In Vitro Model Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
In Vivo Model
Nude mice of both sexes (age: 6-8 weeks, weight: 22-25 g) were purchased from HUNAN SJA LABRATORY ANIMAL CO., LTD (Hunan, China). The EC109 cells stably expressing sh-circBCAR3 or sh-nc were established by infection with corresponding lentivirus vectors. 1 x 106 mL-1 (100 uL) cells were subcutaneously inoculated into the nude mice. The tumor volumes had been measured from day 5 to day 25. On day 25, the xenograft tumors were removed surgically, and the tumor weight was detected.

    Click to Show/Hide
Response regulation CircBCAR3 binds with miR-27a-3p to promote TNPO1 expression. GPX4 protein levels were increased by silencing of circBCAR3. And circBCAR3 promoted the proliferation, migration, invasion, and ferroptosis of esophageal cancer cells by miR-27a-3p.
Unspecific Target
In total 8 item(s) under this target
Experiment 1 Reporting the Ferroptosis-centered Disease Response by This Target [2]
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Drug Allicin Investigative
Responsed Regulator Ubiquitin-like modifier-activating enzyme ATG7 (ATG7) Driver
Pathway Response mTOR signaling pathway hsa04150
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell autophagy
In Vitro Model TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
KYSE-510 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1354
HET-1A cells Normal Homo sapiens CVCL_3702
In Vivo Model
All mice were housed in a specific pathogen-free environment under a standard 12 h light-dark cycle at 25 and had ad libitum access to food and water. Approximately 4 x 106 KYSE510 cells in 100 uL of normal saline were subcutaneously injected into the right flank of mice (n = 20 in total). All mice were allocated to a control or 10 mg/kg allicin group (n = 10 per group), as previously described (Suddek 2014). The mice were orally administered allicin or normal saline once daily for 28 days.

    Click to Show/Hide
Response regulation In summary, allicin may induce cell death in esophageal squamous cell carcinoma (ESCC) cells by activating AMPK/mTOR-mediated autophagy and ferroptosis. Furthermore, ATG5 and ATG7 expression increased in tumors after allicin treatment. In contrast, NCOA4 expression increased, but the protein level of FTH1 and TfR1 decreased in tumors after allicin treatment.
Experiment 2 Reporting the Ferroptosis-centered Disease Response by This Target [2]
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Drug Allicin Investigative
Responsed Regulator Serine/threonine-protein kinase mTOR (MTOR) Suppressor
Pathway Response mTOR signaling pathway hsa04150
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell autophagy
In Vitro Model TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
KYSE-510 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1354
HET-1A cells Normal Homo sapiens CVCL_3702
In Vivo Model
All mice were housed in a specific pathogen-free environment under a standard 12 h light-dark cycle at 25 and had ad libitum access to food and water. Approximately 4 x 106 KYSE510 cells in 100 uL of normal saline were subcutaneously injected into the right flank of mice (n = 20 in total). All mice were allocated to a control or 10 mg/kg allicin group (n = 10 per group), as previously described (Suddek 2014). The mice were orally administered allicin or normal saline once daily for 28 days.

    Click to Show/Hide
Response regulation In summary, allicin may induce cell death in esophageal squamous cell carcinoma (ESCC) cells by activating AMPK/mTOR-mediated autophagy and ferroptosis. Furthermore, ATG5 and ATG7 expression increased in tumors after allicin treatment. In contrast, NCOA4 expression increased, but the protein level of FTH1 and TfR1 decreased in tumors after allicin treatment.
Experiment 3 Reporting the Ferroptosis-centered Disease Response by This Target [2]
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Drug Allicin Investigative
Responsed Regulator Autophagy protein 5 (ATG5) Driver
Pathway Response mTOR signaling pathway hsa04150
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell autophagy
In Vitro Model TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
KYSE-510 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1354
HET-1A cells Normal Homo sapiens CVCL_3702
In Vivo Model
All mice were housed in a specific pathogen-free environment under a standard 12 h light-dark cycle at 25 and had ad libitum access to food and water. Approximately 4 x 106 KYSE510 cells in 100 uL of normal saline were subcutaneously injected into the right flank of mice (n = 20 in total). All mice were allocated to a control or 10 mg/kg allicin group (n = 10 per group), as previously described (Suddek 2014). The mice were orally administered allicin or normal saline once daily for 28 days.

    Click to Show/Hide
Response regulation In summary, allicin may induce cell death in esophageal squamous cell carcinoma (ESCC) cells by activating AMPK/mTOR-mediated autophagy and ferroptosis. Furthermore, ATG5 and ATG7 expression increased in tumors after allicin treatment. In contrast, NCOA4 expression increased, but the protein level of FTH1 and TfR1 decreased in tumors after allicin treatment.
Experiment 4 Reporting the Ferroptosis-centered Disease Response by This Target [3]
Responsed Disease Esophageal cancer [ICD-11: 2B70]
Responsed Drug APR-246 Investigative
Responsed Regulator Cysteine desulfurase (NFS1) Driver
Pathway Response Glutathione metabolism hsa00480
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model NCI-H1299 cells Lung large cell carcinoma Homo sapiens CVCL_0060
OACM5.1 C cells Esophageal adenocarcinoma Homo sapiens CVCL_1842
FLO-1 cells Barrett adenocarcinoma Homo sapiens CVCL_2045
HEK-293T cells Normal Homo sapiens CVCL_0063
In Vivo Model
For FLO-1 LM cell line xenografts, 5 x 106 cells suspended in 100 ul of 1:1 PBS and Matrigel (BD Biosciences) were subcutaneously injected into the right flank of ~6 week-old female nonobese diabeticsevere combined immunodeficient interleukin-2RKO (NSG) mice. PDXs were established and implanted into a dorsal intramuscular pocket of NSG mice as previously described. Mice were randomized to SG deplete or control chow ad libitum (AIN93G rodent diet, Specialty Feeds, Australia) and dosed with eprenetapopt (100 mg/kg) or 0.9% saline, intraperitoneally injected daily, once tumors reached 100 mm3. Tumor volume was assessed blinded to treatment group with caliper measurements every 3 to 4 days and calculated using the formula (length x weight2)/2. Metastatic spread was determined by bioluminescence imaging as previously described involving weekly monitoring using the Xenogen IVIS 100 Imaging System (Caliper Life Science). At experimental end point (tumor volume > 1400 mm3), the whole mouse and its organs were imaged to determine the extent and distribution of metastases. Tumors were weighed and tumor growth inhibition was calculated with the formula [1 - (Tf- Ti)/mean(Cf - Ci)] x 100, where Tf, Ti, Cf, and Ci represent final (f) and initial (i) tumor volume of drug treated (T) and control (C) animals, respectively.

    Click to Show/Hide
Response regulation The study demonstrates that eprenetapopt targets cancer cells through GSH depletion and inhibiting cysteine desulfurase activity of NFS1, leading to iron-dependent, nonapoptotic ferroptosis. The combination of eprenetapopt with dietary serine and glycine restriction synergizes to inhibit esophageal xenograft tumor growth.
Experiment 5 Reporting the Ferroptosis-centered Disease Response by This Target [12]
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator LINC01004 (IncRNA) Suppressor
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
KYSE30 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1351
In Vivo Model
A total of 128 immune active female C57BL/6 mice (6 weeks old) were procured from SLAC Laboratory Animal Co., Ltd. (Shanghai, China). ESCC cells (TE-1 and KYSE-30) resuspended in PBS were mixed with Matrigel and subcutaneously injected into the mice (1 x 106 cells per mouse) at the right flank to induce subcutaneous tumors. When the tumor size reached around 150 mm3, the tumor site was locally exposed to irradiation (2 Gy/d for consecutive 4 d). For antibody injection, the mice were injected with IgG or Anti-SIGECE on day 1, 7, or 14 after the first irradiation exposure. After 28 d, the mice were euthanized via overdosed barbiturate (150 mg/kg). The subcutaneous tumors were collected for IHC. Another group of ESCC cells were injected into mice via tail vein (2 x 106 cells per mouse).

    Click to Show/Hide
Response regulation LINC01004 recruited Spi-1 proto-oncogene (SPI1) in nucleus of TAMs to induce transcriptional activation of SIGLEC9. SIGLEC9 interacted with mucin 1 (MUC1). MUC1 overexpression in esophageal squamous cell carcinoma (ESCC) induced M2 skewing of TAMs, enhanced radioresistance and immunosuppression, and promoted nuclear translocation of -catenin to suppress radiotherapy-induced ferroptosis of ESCC cells.
Experiment 6 Reporting the Ferroptosis-centered Disease Response by This Target [12]
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator Transcription factor PU.1 (SPI1) Suppressor
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
KYSE30 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1351
In Vivo Model
A total of 128 immune active female C57BL/6 mice (6 weeks old) were procured from SLAC Laboratory Animal Co., Ltd. (Shanghai, China). ESCC cells (TE-1 and KYSE-30) resuspended in PBS were mixed with Matrigel and subcutaneously injected into the mice (1 x 106 cells per mouse) at the right flank to induce subcutaneous tumors. When the tumor size reached around 150 mm3, the tumor site was locally exposed to irradiation (2 Gy/d for consecutive 4 d). For antibody injection, the mice were injected with IgG or Anti-SIGECE on day 1, 7, or 14 after the first irradiation exposure. After 28 d, the mice were euthanized via overdosed barbiturate (150 mg/kg). The subcutaneous tumors were collected for IHC. Another group of ESCC cells were injected into mice via tail vein (2 x 106 cells per mouse).

    Click to Show/Hide
Response regulation LINC01004 recruited Spi-1 proto-oncogene (SPI1) in nucleus of TAMs to induce transcriptional activation of SIGLEC9. SIGLEC9 interacted with mucin 1 (MUC1). MUC1 overexpression in esophageal squamous cell carcinoma (ESCC) induced M2 skewing of TAMs, enhanced radioresistance and immunosuppression, and promoted nuclear translocation of -catenin to suppress radiotherapy-induced ferroptosis of ESCC cells.
Experiment 7 Reporting the Ferroptosis-centered Disease Response by This Target [12]
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator Sialic acid-binding Ig-like lectin 9 (SIGLEC9) Suppressor
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
KYSE30 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1351
In Vivo Model
A total of 128 immune active female C57BL/6 mice (6 weeks old) were procured from SLAC Laboratory Animal Co., Ltd. (Shanghai, China). ESCC cells (TE-1 and KYSE-30) resuspended in PBS were mixed with Matrigel and subcutaneously injected into the mice (1 x 106 cells per mouse) at the right flank to induce subcutaneous tumors. When the tumor size reached around 150 mm3, the tumor site was locally exposed to irradiation (2 Gy/d for consecutive 4 d). For antibody injection, the mice were injected with IgG or Anti-SIGECE on day 1, 7, or 14 after the first irradiation exposure. After 28 d, the mice were euthanized via overdosed barbiturate (150 mg/kg). The subcutaneous tumors were collected for IHC. Another group of ESCC cells were injected into mice via tail vein (2 x 106 cells per mouse).

    Click to Show/Hide
Response regulation LINC01004 recruited Spi-1 proto-oncogene (SPI1) in nucleus of TAMs to induce transcriptional activation of SIGLEC9. SIGLEC9 interacted with mucin 1 (MUC1). MUC1 overexpression in esophageal squamous cell carcinoma (ESCC) induced M2 skewing of TAMs, enhanced radioresistance and immunosuppression, and promoted nuclear translocation of -catenin to suppress radiotherapy-induced ferroptosis of ESCC cells.
Experiment 8 Reporting the Ferroptosis-centered Disease Response by This Target [12]
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator Mucin-1 (MUC1) Suppressor
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
KYSE30 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1351
In Vivo Model
A total of 128 immune active female C57BL/6 mice (6 weeks old) were procured from SLAC Laboratory Animal Co., Ltd. (Shanghai, China). ESCC cells (TE-1 and KYSE-30) resuspended in PBS were mixed with Matrigel and subcutaneously injected into the mice (1 x 106 cells per mouse) at the right flank to induce subcutaneous tumors. When the tumor size reached around 150 mm3, the tumor site was locally exposed to irradiation (2 Gy/d for consecutive 4 d). For antibody injection, the mice were injected with IgG or Anti-SIGECE on day 1, 7, or 14 after the first irradiation exposure. After 28 d, the mice were euthanized via overdosed barbiturate (150 mg/kg). The subcutaneous tumors were collected for IHC. Another group of ESCC cells were injected into mice via tail vein (2 x 106 cells per mouse).

    Click to Show/Hide
Response regulation LINC01004 recruited Spi-1 proto-oncogene (SPI1) in nucleus of TAMs to induce transcriptional activation of SIGLEC9. SIGLEC9 interacted with mucin 1 (MUC1). MUC1 overexpression in esophageal squamous cell carcinoma (ESCC) induced M2 skewing of TAMs, enhanced radioresistance and immunosuppression, and promoted nuclear translocation of -catenin to suppress radiotherapy-induced ferroptosis of ESCC cells.
Nuclear receptor coactivator 4 (NCOA4)
In total 1 item(s) under this target
Experiment 1 Reporting the Ferroptosis-centered Disease Response by This Target [2]
Target for Ferroptosis Driver
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Drug Allicin Investigative
Pathway Response mTOR signaling pathway hsa04150
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell autophagy
In Vitro Model TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
KYSE-510 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1354
HET-1A cells Normal Homo sapiens CVCL_3702
In Vivo Model
All mice were housed in a specific pathogen-free environment under a standard 12 h light-dark cycle at 25 and had ad libitum access to food and water. Approximately 4 x 106 KYSE510 cells in 100 uL of normal saline were subcutaneously injected into the right flank of mice (n = 20 in total). All mice were allocated to a control or 10 mg/kg allicin group (n = 10 per group), as previously described (Suddek 2014). The mice were orally administered allicin or normal saline once daily for 28 days.

    Click to Show/Hide
Response regulation In summary, allicin may induce cell death in esophageal squamous cell carcinoma (ESCC) cells by activating AMPK/mTOR-mediated autophagy and ferroptosis. Furthermore, ATG5 and ATG7 expression increased in tumors after allicin treatment. In contrast, NCOA4 expression increased, but the protein level of FTH1 and TfR1 decreased in tumors after allicin treatment.
Heme oxygenase 1 (HMOX1)
In total 1 item(s) under this target
Experiment 1 Reporting the Ferroptosis-centered Disease Response by This Target [4]
Target for Ferroptosis Driver/Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Drug 5-aminolevulinic acid Approved
Pathway Response Fatty acid metabolism hsa01212
Ferroptosis hsa04216
Cell Process Cell ferroptosis
Cell proliferation
In Vitro Model KYSE30 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1351
KYSE-510 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1354
MKN45 cells Gastric adenocarcinoma Homo sapiens CVCL_0434
In Vivo Model
KYSE30 cells were subcutaneously inoculated with 5 x 106 cells per site into both flanks on day 0. At 1 week after transplantation, tumor-bearing mice were randomly assigned to one of the following three groups: (1) saline as a control, (2) 10 mg/kg/day of 5-ALA, or (3) 30 mg/kg/day of 5-ALA. The treatment groups were orally administered 5-ALA once daily for 4 weeks, and the control group was orally administered saline during the same period.

    Click to Show/Hide
Response regulation Modulation of GPX4 and HMOX1 by 5-aminolevulinic acid (5-ALA) induced ferroptosis in esophageal squamous cell carcinoma (ESCC). Furthermore, 5-ALA led to an increase in lipid peroxidation and exerted an antitumor effect in various cancer cell lines, which was inhibited by ferrostatin-1. Thus, 5-ALA could be a promising new therapeutic agent for ESCC.
Cystine/glutamate transporter (SLC7A11)
In total 8 item(s) under this target
Experiment 1 Reporting the Ferroptosis-centered Disease Response by This Target [10]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator Disintegrin and metalloproteinase domain-containing protein 23 (ADAM23) Driver
Pathway Response Glutathione metabolism hsa00480
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
In Vitro Model EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
HET-1A cells Normal Homo sapiens CVCL_3702
Response regulation ARHGEF26-AS1 facilitated ferroptosis but restrained cell growth and positively regulated ADAM23 by sponging miR-372-3p in esophageal squamous cell carcinoma (ESCC). Overexpression of ARHGEF26-AS1 upregulated the protein levels of ADAM23 but depleted the protein levels of GPX4, 3SLC3A2, and SLC7A11.
Experiment 2 Reporting the Ferroptosis-centered Disease Response by This Target [6]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator Frizzled-3 (FZD3) Suppressor
Pathway Response Wnt signaling pathway hsa04310
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell invasion
In Vitro Model EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
KYSE-70 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1356
hEECs (Human esophageal epithelial cells)
In Vivo Model
BALB/c nude male mice of 4 weeks old were purchased from the Model Animal Research Center of Nanjing University (Nanjing, China). After one week of adaptive feeding, EC9706 cells (3 x 106) stably expressing sh-NC and sh-circPVT1, sh-NC + 5-FU and sh-circPVT1 + 5-FU were subcutaneously were injected into the right flank of the nude mice in a serum-free DMEM medium.

    Click to Show/Hide
Response regulation CircPVT1 regulated the chemosensitivity of esophageal squamous cell carcinoma cells through ROS and Wnt/-catenin pathwaysviamiR-30a-5p/FZD3. Knockdown of circPVT1 promoted chemosensitivity in ESCC by increasing ferroptosis via downregulating GPX4 and SLC7A11.
Experiment 3 Reporting the Ferroptosis-centered Disease Response by This Target [6]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator hsa-miR-30a-5p (miRNA) Driver
Pathway Response Wnt signaling pathway hsa04310
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell invasion
In Vitro Model EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
KYSE-70 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1356
hEECs (Human esophageal epithelial cells)
In Vivo Model
BALB/c nude male mice of 4 weeks old were purchased from the Model Animal Research Center of Nanjing University (Nanjing, China). After one week of adaptive feeding, EC9706 cells (3 x 106) stably expressing sh-NC and sh-circPVT1, sh-NC + 5-FU and sh-circPVT1 + 5-FU were subcutaneously were injected into the right flank of the nude mice in a serum-free DMEM medium.

    Click to Show/Hide
Response regulation CircPVT1 regulated the chemosensitivity of esophageal squamous cell carcinoma cells through ROS and Wnt/-catenin pathways via miR-30a-5p/FZD3. Knockdown of circPVT1 promoted chemosensitivity in ESCC by increasing ferroptosis via downregulating GPX4 and SLC7A11.
Experiment 4 Reporting the Ferroptosis-centered Disease Response by This Target [10]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator hsa-miR-372-3p (miRNA) Suppressor
Pathway Response Glutathione metabolism hsa00480
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
In Vitro Model EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
HET-1A cells Normal Homo sapiens CVCL_3702
Response regulation ARHGEF26-AS1 facilitated ferroptosis but restrained cell growth and positively regulated ADAM23 by sponging miR-372-3p in esophageal squamous cell carcinoma (ESCC). Overexpression of ARHGEF26-AS1 upregulated the protein levels of ADAM23 but depleted the protein levels of GPX4, SLC3A2, and SLC7A11.
Experiment 5 Reporting the Ferroptosis-centered Disease Response by This Target [11]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator hsa-miR-513a-3p (miRNA) Driver
Pathway Response Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell apoptosis
Cell proliferation
In Vitro Model hESCCs (Esophageal squamous cancer cells)
Response regulation Downregulation of BBOX1-AS1 inhibits cell proliferation, and metastasis accelerates cell apoptosis and ferroptosis in esophageal squamous cell cancer by upregulating miR-513a-3p to reduce SLC7A11 expression. These findings may provide novel insights into the diagnosis and treatment of ESCC.
Experiment 6 Reporting the Ferroptosis-centered Disease Response by This Target [10]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator ARHGEF26-AS1 (IncRNA) Driver
Pathway Response Glutathione metabolism hsa00480
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
In Vitro Model EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
HET-1A cells Normal Homo sapiens CVCL_3702
Response regulation ARHGEF26-AS1 facilitated ferroptosis but restrained cell growth and positively regulated ADAM23 by sponging miR-372-3p in esophageal squamous cell carcinoma (ESCC). Overexpression of ARHGEF26-AS1 upregulated the protein levels of ADAM23 but depleted the protein levels of GPX4, SLC3A2, and SLC7A11.
Experiment 7 Reporting the Ferroptosis-centered Disease Response by This Target [11]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator BBOX1-AS1 (IncRNA) Suppressor
Pathway Response Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell apoptosis
Cell proliferation
In Vitro Model hESCCs (Esophageal squamous cancer cells)
Response regulation Downregulation of BBOX1-AS1 inhibits cell proliferation, and metastasis accelerates cell apoptosis and ferroptosis in esophageal squamous cell cancer by upregulating miR-513a-3p to reduce SLC7A11 expression. These findings may provide novel insights into the diagnosis and treatment of ESCC.
Experiment 8 Reporting the Ferroptosis-centered Disease Response by This Target [6]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator CircPVT1 (circRNA) Suppressor
Pathway Response Wnt signaling pathway hsa04310
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell invasion
In Vitro Model EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
KYSE-70 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1356
hEECs (Human esophageal epithelial cells)
In Vivo Model
BALB/c nude male mice of 4 weeks old were purchased from the Model Animal Research Center of Nanjing University (Nanjing, China). After one week of adaptive feeding, EC9706 cells (3 x 106) stably expressing sh-NC and sh-circPVT1, sh-NC + 5-FU and sh-circPVT1 + 5-FU were subcutaneously were injected into the right flank of the nude mice in a serum-free DMEM medium.

    Click to Show/Hide
Response regulation CircPVT1 regulated the chemosensitivity of esophageal squamous cell carcinoma cells through ROS and Wnt/-catenin pathwaysviamiR-30a-5p/FZD3. Knockdown of circPVT1 promoted chemosensitivity in ESCC by increasing ferroptosis via downregulating GPX4 and SLC7A11.
4F2 cell-surface antigen heavy chain (SLC3A2)
In total 3 item(s) under this target
Experiment 1 Reporting the Ferroptosis-centered Disease Response by This Target [10]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator Disintegrin and metalloproteinase domain-containing protein 23 (ADAM23) Driver
Pathway Response Glutathione metabolism hsa00480
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
In Vitro Model EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
HET-1A cells Normal Homo sapiens CVCL_3702
Response regulation ARHGEF26-AS1 facilitated ferroptosis but restrained cell growth and positively regulated ADAM23 by sponging miR-372-3p in esophageal squamous cell carcinoma (ESCC). Overexpression of ARHGEF26-AS1 upregulated the protein levels of ADAM23 but depleted the protein levels of GPX4, SLC3A2, and SLC7A11.
Experiment 2 Reporting the Ferroptosis-centered Disease Response by This Target [10]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator hsa-miR-372-3p (miRNA) Suppressor
Pathway Response Glutathione metabolism hsa00480
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
In Vitro Model EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
HET-1A cells Normal Homo sapiens CVCL_3702
Response regulation ARHGEF26-AS1 facilitated ferroptosis but restrained cell growth and positively regulated ADAM23 by sponging miR-372-3p in esophageal squamous cell carcinoma (ESCC). Overexpression of ARHGEF26-AS1 upregulated the protein levels of ADAM23 but depleted the protein levels of GPX4, SLC3A2, and SLC7A11.
Experiment 3 Reporting the Ferroptosis-centered Disease Response by This Target [10]
Target for Ferroptosis Suppressor
Responsed Disease Esophageal squamous cell carcinoma [ICD-11: 2B70]
Responsed Regulator ARHGEF26-AS1 (IncRNA) Driver
Pathway Response Glutathione metabolism hsa00480
Fatty acid metabolism hsa01212
Cell Process Cell ferroptosis
Cell proliferation
Cell migration
In Vitro Model EC9706 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_E307
TE-1 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_1759
Eca-109 cells Esophageal squamous cell carcinoma Homo sapiens CVCL_6898
HET-1A cells Normal Homo sapiens CVCL_3702
Response regulation ARHGEF26-AS1 facilitated ferroptosis but restrained cell growth and positively regulated ADAM23 by sponging miR-372-3p in esophageal squamous cell carcinoma (ESCC). Overexpression of ARHGEF26-AS1 upregulated the protein levels of ADAM23 but depleted the protein levels of GPX4, SLC3A2, and SLC7A11.
References
Ref 1 Oridonin induces ferroptosis by inhibiting gamma-glutamyl cycle in TE1 cells. Phytother Res. 2021 Jan;35(1):494-503. doi: 10.1002/ptr.6829. Epub 2020 Aug 31.
Ref 2 Allicin promotes autophagy and ferroptosis in esophageal squamous cell carcinoma by activating AMPK/mTOR signaling. Heliyon. 2022 Oct 12;8(10):e11005. doi: 10.1016/j.heliyon.2022.e11005. eCollection 2022 Oct.
Ref 3 Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction. Sci Adv. 2022 Sep 16;8(37):eabm9427. doi: 10.1126/sciadv.abm9427. Epub 2022 Sep 14.
Ref 4 Antitumor Effect of 5-Aminolevulinic Acid Through Ferroptosis in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2021 Jul;28(7):3996-4006. doi: 10.1245/s10434-020-09334-4. Epub 2020 Nov 18.
Ref 5 DNAJB6 Promotes Ferroptosis in Esophageal Squamous Cell Carcinoma. Dig Dis Sci. 2020 Jul;65(7):1999-2008. doi: 10.1007/s10620-019-05929-4. Epub 2019 Nov 8.
Ref 6 Circular RNA CircPVT1 Inhibits 5-Fluorouracil Chemosensitivity by Regulating Ferroptosis Through MiR-30a-5p/FZD3 Axis in Esophageal Cancer Cells. Front Oncol. 2021 Dec 13;11:780938. doi: 10.3389/fonc.2021.780938. eCollection 2021.
Ref 7 CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p. Mol Cancer. 2022 Jul 15;21(1):145. doi: 10.1186/s12943-022-01615-8.
Ref 8 Cysteinyl-tRNA Synthetase 1 Promotes Ferroptosis-Induced Cell Death via Regulating GPX4 Expression. J Oncol. 2022 Sep 28;2022:4849174. doi: 10.1155/2022/4849174. eCollection 2022.
Ref 9 LncRNA OIP5-AS1 Knockdown Facilitated the Ferroptosis and Immune Evasion by Modulating the GPX4 in Oesophageal Carcinoma. Comput Math Methods Med. 2022 Jul 15;2022:8103198. doi: 10.1155/2022/8103198. eCollection 2022.
Ref 10 Mechanism and Role of the Neuropeptide LGI1 Receptor ADAM23 in Regulating Biomarkers of Ferroptosis and Progression of Esophageal Cancer. Dis Markers. 2021 Dec 30;2021:9227897. doi: 10.1155/2021/9227897. eCollection 2021.
Ref 11 lncRNA BBOX1-AS1 silencing inhibits esophageal squamous cell cancer progression by promoting ferroptosis via miR-513a-3p/SLC7A11 axis. Eur J Pharmacol. 2022 Nov 5;934:175317. doi: 10.1016/j.ejphar.2022.175317. Epub 2022 Oct 7.
Ref 12 LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma. Cancer Immunol Immunother. 2023 Jun;72(6):1835-1851. doi: 10.1007/s00262-022-03364-5. Epub 2023 Jan 23.